Hasil Pencarian - Sorilla Prey

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Congenital haemangiomas: a single-centre retrospective review

    Congenital haemangiomas: a single-centre retrospective review oleh Nicolas Grenier, Victoire Braun, Sorilla Prey, Carlotta Gurioli, Franck Boralevi, Alain Taieb, Maya Loot, Marie-Laure Jullie, Christine Léauté-Labrèze

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Is Infantile Hemangioma a Neuroendocrine Tumor?

    Is Infantile Hemangioma a Neuroendocrine Tumor? oleh Priscilla Kaulanjan-Checkmodine, Sandra Oucherif, Sorilla Prey, Etienne Gontier, Sabrina Lacomme, Maya Loot, Marijana Miljkovic-Licina, Muriel Cario, Christine Léauté-Labrèze, Alain Taieb, François Moisan, Hamid Reza Rezvani

    Diterbitkan 2022-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study

    Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study oleh Samuel Bitoun, Marie Kostine, Christophe Richez, Thomas Barnetche, Thierry Schaeverbeke, Gael Mouterde, Marie-Elise Truchetet, Maéva Zysman, Amaury Daste, Sorilla Prey, Alice Tison, Rémi Veillon, Caroline Dutriaux, Anne Pham-Ledard, Marie Beylot-Barry, Marine Gross-Goupil, Félix Lefort, Alexandra Ladouceur, Emilie Gerard, Charlotte Domblides, Baptiste Sionneau, Mathieu Larroquette

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional studyCapsule Summary

    Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional studyCapsule S... oleh Léa Dousset, MD, Alize Pacaud, MD, Thomas Barnetche, PhD, Marie Kostine, MD, PhD, Caroline Dutriaux, MD, Anne Pham-Ledard, MD, PhD, Marie Beylot-Barry, MD, PhD, Emilie Gérard, MD, Sorilla Prey, MD, PhD, Nicolas Andreu, BSc, Katia Boniface, PhD, Julien Seneschal, MD, PhD

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

    961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1... oleh Caroline Robert, Helena Escuin-Ordinas, Juan Martin-Liberal, Miguel Sanmamed, Stephane Dalle, Ana Arance, Marya Chaney, Sorilla Prey, Alfonso Berrocal, Caroline Dutriaux, Iván Márquez Rodas, Philippe Saiag, Luis de la Cruz Merino, Juan Rodríguez-Moreno, Eduardo Castañón Álvarez, Pablo Cerezuela-Fuentes, Henry Montaudie, María González Cao, Julie Charles, María Pilar López Criado, Enrique de Miguel, Elisa Funk-Brentano, Roberto Huertas, Delvys Rodríguez Abreu, Eva Muñoz Couselo, Javier Sánchez López, Sonia Maciá

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: